Sanofi Comprehensive Income
Sanofi (SNYNF) reported Comprehensive Income of EUR 3.16 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncome · last filed 2026-02-17
| Period end | Comprehensive Income 6 month | Comprehensive Income 6 month as first filed | Comprehensive Income 12 month | Comprehensive Income 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 3.16B EUR 20-F · filed 2026-02-17 | |||
| 2025-06-30 | 1.06B EUR 6-K · filed 2025-10-27 | |||
| 2024-12-31 | 4.55B EUR 6-K · filed 2025-10-27 | 8.05B EUR 20-F · filed 2026-02-17 | ||
| 2024-06-30 | 3.50B EUR 6-K · filed 2025-10-27 | |||
| 2023-12-31 | 1.35B EUR 6-K · filed 2024-07-25 | 3.83B EUR 20-F · filed 2026-02-17 | ||
| 2023-06-30 | 2.48B EUR 6-K · filed 2024-07-25 | |||
| 2022-12-31 | 3.76B EUR 6-K · filed 2023-07-28 | 11.25B EUR 20-F · filed 2025-02-13 | ||
| 2022-06-30 | 7.49B EUR 6-K · filed 2023-07-28 | |||
| 2021-12-31 | 5.36B EUR 6-K · filed 2022-07-28 | 9.59B EUR 20-F · filed 2024-02-23 | ||
| 2021-06-30 | 4.22B EUR 6-K · filed 2022-07-28 | 4.25B EUR 6-K · filed 2021-07-29 | ||
| 2020-12-31 | -123.00M EUR 6-K · filed 2021-07-29 | 8.32B EUR 20-F · filed 2023-02-24 | 8.34B EUR 20-F · filed 2021-03-04 | |
| 2020-06-30 | 8.46B EUR 6-K · filed 2021-07-29 | |||
| 2019-12-31 | 2.37B EUR 6-K · filed 2020-07-29 | 3.47B EUR 20-F · filed 2022-02-23 | 3.49B EUR 20-F · filed 2020-03-05 | |
| 2019-06-30 | 1.12B EUR 6-K · filed 2020-07-29 | |||
| 2018-12-31 | 5.37B EUR 20-F · filed 2021-03-04 | |||
| 2017-12-31 | 5.86B EUR 20-F · filed 2020-03-05 | 5.87B EUR 20-F/A · filed 2018-03-16 | ||
| 2016-12-31 | 5.73B EUR 20-F · filed 2019-03-08 | |||
| 2015-12-31 | 6.75B EUR 20-F/A · filed 2018-03-16 |